• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Hu-Friedy

Anonymous board for Hu-Friedy
Replies
60
Views
31K
anonymous
Replies
2
Views
3K
anonymous
Replies
3
Views
10K
Anonymous